International audienceToxic epidermal necrolysis (TEN) is characterized by an acute detachment and destruction of keratinocytes, affecting large areas of the skin. It is often related to adverse drug reactions. Previous studies have shown that effector CD8+ T cells, which accumulate in the blister fluid, are functionally cytotoxic and act through a classical perforin/granzyme B pathway. It has recently been shown that these cytotoxic T cells also secrete granulysin peptide, which is lethal to keratinocytes. These cytotoxic T cells exert their killer activity against autologous keratinocytes in the presence of the drug. However, they are unlikely to be the only effectors of TEN. We therefore searched for soluble death factors in the blister ...
Toxic epidermal necrolysis (TEN) is a rare but life threatening mucocutaneous reaction to drugs or t...
Toxic epidermal necrolysis (TEN) is the most severe form of drug-induced skin reaction and includes ...
We determined the feasibility of using an anti-desmoglein (Dsg) mAb, Px44, to deliver a biologically...
International audienceToxic epidermal necrolysis (TEN) is characterized by an acute detachment and d...
Toxic epidermal necrolysis is a rare disease observed as a consequence of adverse reactions to drugs...
Toxic epidermal necrolysis (TEN) is a rare, life-threatening drug-induced skin disease with a mortal...
Toxic epidermal necrolysis (TEN) is a rare, life-threatening drug-induced skin disease with a mortal...
Toxic epidermal necrolysis (TEN) is a rare drug-induced disease for which the pathomechanism remains...
Toxic epidermal necrolysis (TEN) is a life-threatening drug-induced cutaneous reaction characterize...
Using serial analysis of gene expression we have previously identified the expression of several pro...
Toxic epidermal necrolysis (TEN) is a rare but potentially fatal drug hypersensitivity reaction. Alt...
Toxic epidermal necrolysis (TEN) is a severe immune-mediated adverse cutaneous drug eruption charact...
BACKGROUND: Drug-induced toxic epidermal necrolysis (TEN) probably results from a complex and specif...
Drug-induced toxic epidermal necrolysis (TEN) is a rare but potentially lethal bullous disease whose...
Toxic epidermal necrolysis (TEN) is a severe immune-mediated adverse cutaneous drug eruption charact...
Toxic epidermal necrolysis (TEN) is a rare but life threatening mucocutaneous reaction to drugs or t...
Toxic epidermal necrolysis (TEN) is the most severe form of drug-induced skin reaction and includes ...
We determined the feasibility of using an anti-desmoglein (Dsg) mAb, Px44, to deliver a biologically...
International audienceToxic epidermal necrolysis (TEN) is characterized by an acute detachment and d...
Toxic epidermal necrolysis is a rare disease observed as a consequence of adverse reactions to drugs...
Toxic epidermal necrolysis (TEN) is a rare, life-threatening drug-induced skin disease with a mortal...
Toxic epidermal necrolysis (TEN) is a rare, life-threatening drug-induced skin disease with a mortal...
Toxic epidermal necrolysis (TEN) is a rare drug-induced disease for which the pathomechanism remains...
Toxic epidermal necrolysis (TEN) is a life-threatening drug-induced cutaneous reaction characterize...
Using serial analysis of gene expression we have previously identified the expression of several pro...
Toxic epidermal necrolysis (TEN) is a rare but potentially fatal drug hypersensitivity reaction. Alt...
Toxic epidermal necrolysis (TEN) is a severe immune-mediated adverse cutaneous drug eruption charact...
BACKGROUND: Drug-induced toxic epidermal necrolysis (TEN) probably results from a complex and specif...
Drug-induced toxic epidermal necrolysis (TEN) is a rare but potentially lethal bullous disease whose...
Toxic epidermal necrolysis (TEN) is a severe immune-mediated adverse cutaneous drug eruption charact...
Toxic epidermal necrolysis (TEN) is a rare but life threatening mucocutaneous reaction to drugs or t...
Toxic epidermal necrolysis (TEN) is the most severe form of drug-induced skin reaction and includes ...
We determined the feasibility of using an anti-desmoglein (Dsg) mAb, Px44, to deliver a biologically...